Seok June Pill, Kim Young Jin, Cho Hyun Min, Ryu Han Young, Hwang Wan Jin, Sung Tae Yun
Department of Thoracic and Cardiovascular Surgery, Konyang University Hospital, Konyang University College of Medicine, Korea.
Department of Thoracic and Cardiovascular Surgery, Pusan National University Hospital, Pusan National University School of Medicine, Korea.
Korean J Thorac Cardiovasc Surg. 2014 Feb;47(1):26-31. doi: 10.5090/kjtcs.2014.47.1.26. Epub 2014 Feb 5.
When managing patients who require repeated venous access, gaining a viable intravenous route has been problematic. To improve the situation, various studies on techniques for venous access have been conducted. The aim of this study is to evaluate the clinical results of complications following totally implanted central venous access port (TICVAP) insertion.
A retrospective analysis was conducted on 163 patients, from December 2008 to March 2013. The occurrence of complications was studied in three separate periods of catheter use: the intraoperative period, postoperative period, and period during the treatment.
A total of 165 cases of TICVAP insertions involving 156 patients were included in the final analysis. There were 35 complications (21%) overall. Among these, 31 cases of complications (19%) occurred during the treatment period and the other 4 cases were intraoperative and postoperative complications (2%). There were no statistically significant differences in age and gender of the patients between the two groups to be risk factors (p=0.147, p=0.08). Past history of chemotherapy, initial laboratory findings, and the locations of TICVAP insertion also showed no statistical significance as risk factors (p>0.05).
Because the majority of complications occurred after port placement and during treatment, meticulous care and management and appropriate education are necessary when using TICVAPs.
在管理需要反复进行静脉通路的患者时,获得可行的静脉途径一直存在问题。为改善这种情况,已对静脉通路技术进行了各种研究。本研究的目的是评估完全植入式中心静脉通路端口(TICVAP)插入术后并发症的临床结果。
对2008年12月至2013年3月期间的163例患者进行回顾性分析。在导管使用的三个不同时期研究并发症的发生情况:术中、术后以及治疗期间。
最终分析纳入了涉及156例患者的165例TICVAP插入病例。总共发生35例并发症(21%)。其中,31例并发症(19%)发生在治疗期间,另外4例为术中及术后并发症(2%)。两组患者作为危险因素的年龄和性别无统计学显著差异(p = 0.147,p = 0.08)。化疗既往史、初始实验室检查结果以及TICVAP插入部位作为危险因素也无统计学意义(p>0.05)。
由于大多数并发症发生在端口置入后和治疗期间,使用TICVAP时需要精心护理和管理以及适当的教育。